Trial Profile
Phase I/IIa study of KUR 211 in patients with chronic venous leg ulcers
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs KUR 211 (Primary)
- Indications Leg ulcer; Wounds
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kuros Biosciences
- 08 Mar 2016 New trial record